LTZ Therapeutics
Immunotherapy company targeting oncology and autoimmune diseases.
About
LTZ Therapeutics is a clinical-stage biotechnology company developing novel immunotherapies that empower myeloid cells to enhance anti-tumor immunity. Their Universal Myeloid Cell Engager (U-MCETM) platform aims to address unmet clinical needs in oncology and autoimmune diseases by directly engaging myeloid cells to activate killing mechanisms and reprogram the tumor microenvironment. Teams look it up for Biotechnology, Pharmaceuticals, HealthTech.
Frequently asked
What does LTZ Therapeutics do?
LTZ Therapeutics is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, HealthTech, Biotech. It is based in Redwood City, California, USA and was founded in 2021. Public records show $76M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has LTZ Therapeutics raised?
LTZ Therapeutics has raised a total of $76M in funding. The most recent round on record is Series B.
Where is LTZ Therapeutics headquartered?
LTZ Therapeutics is headquartered in Redwood City, California, USA.
When was LTZ Therapeutics founded?
LTZ Therapeutics was founded in 2021.
What industry does LTZ Therapeutics operate in?
LTZ Therapeutics operates in Biotechnology, Pharmaceuticals, HealthTech, Biotech, Drug Discovery.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.